Clearwater Capital Advisors’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $640K | Hold |
1,818
| – | – | 0.05% | 103 |
|
|
2025
Q4 | $595K | Hold |
1,818
| – | – | 0.05% | 105 |
|
|
2025
Q3 | $513K | Hold |
1,818
| – | – | 0.04% | 115 |
|
|
2025
Q2 | $508K | Hold |
1,818
| – | – | 0.05% | 110 |
|
|
2025
Q1 | $566K | Sell |
1,818
-11
| -0.6% | -$3.25K | 0.05% | 101 |
|
|
2024
Q4 | $477K | Hold |
1,829
| – | – | 0.05% | 112 |
|
|
2024
Q3 | $589K | Sell |
1,829
-11
| -0.6% | -$3.6K | 0.06% | 99 |
|
|
2024
Q2 | $575K | Sell |
1,840
-19
| -1% | -$5.58K | 0.06% | 92 |
|
|
2024
Q1 | $529K | Sell |
1,859
-13
| -0.7% | -$3.8K | 0.06% | 93 |
|
|
2023
Q4 | $539K | Buy |
1,872
+69
| +4% | +$18.8K | 0.06% | 90 |
|
|
2023
Q3 | $485K | Hold |
1,803
| – | – | 0.06% | 86 |
|
|
2023
Q2 | $400K | Hold |
1,803
| – | – | 0.05% | 98 |
|
|
2023
Q1 | $436K | Sell |
1,803
-30
| -2% | -$7.36K | 0.05% | 96 |
|
|
2022
Q4 | $481K | Sell |
1,833
-14
| -0.8% | -$3.75K | 0.06% | 99 |
|
|
2022
Q3 | $416K | Sell |
1,847
-36
| -2% | -$8.73K | 0.06% | 104 |
|
|
2022
Q2 | $458K | Buy |
1,883
+50
| +3% | +$12.3K | 0.06% | 97 |
|
|
2022
Q1 | $443K | Hold |
1,833
| – | – | 0.05% | 108 |
|
|
2021
Q4 | $412K | Hold |
1,833
| – | – | 0.05% | 112 |
|
|
2021
Q3 | $390K | Hold |
1,833
| – | – | 0.05% | 112 |
|
|
2021
Q2 | $447K | Sell |
1,833
-1
| -0.1% | -$246 | 0.05% | 108 |
|
|
2021
Q1 | $456K | Hold |
1,834
| – | – | 0.06% | 110 |
|
|
2020
Q4 | $422K | Buy |
1,834
+1
| +0.1% | +$231 | 0.06% | 106 |
|
|
2020
Q3 | $466K | Hold |
1,833
| – | – | 0.07% | 97 |
|
|
2020
Q2 | $432K | Sell |
1,833
-25
| -1% | -$5.7K | 0.07% | 98 |
|
|
2020
Q1 | $377K | Sell |
1,858
-51
| -3% | -$11.1K | 0.08% | 105 |
|
|
2019
Q4 | $460K | Sell |
1,909
-19
| -1% | -$4.19K | 0.08% | 128 |
|
|
2019
Q3 | $373K | Hold |
1,928
| – | – | 0.07% | 155 |
|
|
2019
Q2 | $355K | Hold |
1,928
| – | – | 0.06% | 158 |
|
|
2019
Q1 | $366K | Hold |
1,928
| – | – | 0.07% | 157 |
|
|
2018
Q4 | $375K | Sell |
1,928
-70
| -4% | -$13.7K | 0.08% | 158 |
|
|
2018
Q3 | $414K | Sell |
1,998
-289
| -13% | -$57K | 0.08% | 149 |
|
|
2018
Q2 | $422K | Hold |
2,287
| – | – | 0.09% | 134 |
|
|
2018
Q1 | $390K | Hold |
2,287
| – | – | 0.08% | 136 |
|
|
2017
Q4 | $398K | Hold |
2,287
| – | – | 0.09% | 133 |
|
|
2017
Q3 | $424K | Hold |
2,287
| – | – | 0.1% | 127 |
|
|
2017
Q2 | $394K | Sell |
2,287
-150
| -6% | -$24.4K | 0.1% | 124 |
|
|
2017
Q1 | $395K | Buy |
2,437
+504
| +26% | +$83.7K | 0.11% | 124 |
|
|
2016
Q4 | $291K | Buy |
+1,933
| New | +$291K | 0.1% | 125 |
|
Other funds holding AMGN
VCM
VPM
Clearwater Capital Advisors's AMGN Position: Q1 2026 in Review
Clearwater Capital Advisors held its Amgen (AMGN) position steady in Q1 2026 at 1,818 shares worth $640K. The position accounts for 0.05% of the portfolio, ranked #103.
Clearwater Capital Advisors first reported a position in AMGN in Q4 2016 and has held it in 38 quarters since. 3,128 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.
- Clearwater Capital Advisors held 1,818 shares of Amgen worth $640K as of Q1 2026.
- Clearwater Capital Advisors left its Amgen share count unchanged in Q1 2026.
- Amgen made up 0.05% of Clearwater Capital Advisors's portfolio in Q1 2026, its #103 holding.
- Clearwater Capital Advisors first reported a position in Amgen in Q4 2016 and has held it in 38 quarters since.
- 3,128 funds tracked by Wall St. Rank held Amgen as of Q1 2026.
Based on Clearwater Capital Advisors's 13F filing for Q1 2026, filed 13 May 2026.